A detailed history of Anfield Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Anfield Capital Management, LLC holds 346 shares of PFE stock, worth $10,293. This represents 0.0% of its overall portfolio holdings.

Number of Shares
346
Holding current value
$10,293
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$25.26 - $29.6 $8,739 - $10,241
346 New
346 $9,000
Q4 2021

Feb 03, 2022

SELL
$41.32 - $61.25 $11,569 - $17,150
-280 Closed
0 $0
Q3 2021

Nov 04, 2021

BUY
$39.25 - $50.42 $10,990 - $14,117
280 New
280 $12,000
Q1 2020

May 07, 2020

SELL
$27.03 - $38.62 $142,502 - $203,604
-5,272 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $173,554 - $196,961
5,272 New
5,272 $201,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $167B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Anfield Capital Management, LLC Portfolio

Follow Anfield Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anfield Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anfield Capital Management, LLC with notifications on news.